NLRC5 promotes the activation of classical NF-κB signaling induced by LPS by forming a complex with IKKα/β and enhancing their phosphorylation. Nlrc5 deficiency inhibits microglial activation and alleviates depressive-like behaviors in LPS and CUMS-induced mouse models of depression. Here, CHUK is linked to depressive disorder.